Catalys Pacific Fund, LP 4
4 · Mineralys Therapeutics, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Slingsby Brian Taylor
Director10% Owner
Transactions
- Other
Stock Option
2025-02-13+32,900→ 32,900 total(indirect: See footnote)Exercise: $10.20Exp: 2035-02-13→ Common Stock (32,900 underlying) - Award
Stock Option
2025-02-13+32,900→ 32,900 totalExercise: $10.20Exp: 2035-02-13→ Common Stock (32,900 underlying) - Other
Stock Option
2025-02-13−32,900→ 0 totalExercise: $10.20Exp: 2035-02-13→ Common Stock (32,900 underlying)
Footnotes (3)
- [F1]The stock option vests in 12 substantially equal monthly installments following the date of grant.
- [F2]Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP.
- [F3]Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.